ChemoCentryx, Inc.
(NASDAQ : CCXI)

( )
CCXI PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Binary Options?
We'll teach you the best ways to trade binaries.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
AMGNAmgen Inc.
0.17%203.561.3%$427.08m
BIIBBiogen Inc.
-0.93%225.601.3%$388.53m
GILDGilead Sciences, Inc.
-0.35%65.000.9%$366.13m
CELGCelgene Corporation
0.82%101.801.3%$356.32m
ILMNIllumina, Inc.
0.28%310.553.5%$253.40m
REGNRegeneron Pharmaceuticals, Inc.
0.73%301.572.6%$219.86m
EXASExact Sciences Corporation
-0.20%97.3924.1%$203.99m
ALXNAlexion Pharmaceuticals, Inc.
0.48%99.992.0%$181.39m
VRTXVertex Pharmaceuticals Incorporated
0.93%177.721.9%$178.93m
AAgilent Technologies, Inc.
-0.47%74.921.6%$143.96m
SRPTSarepta Therapeutics, Inc.
0.81%87.4414.6%$138.15m
BMRNBioMarin Pharmaceutical Inc.
-0.06%67.904.3%$95.86m
SGENSeattle Genetics, Inc.
2.48%85.946.2%$90.55m
NKTRNektar Therapeutics
1.31%17.775.5%$84.92m
ALDRAlder Biopharmaceuticals, Inc.
0.16%18.9010.2%$83.36m

Company Profile

ChemoCentryx, Inc. is a biopharmaceutical company engages in the development and commercialization of medicines. It focuses on inflammatory disorders, autoimmune diseases, and cancer. Its drug candidates such as Avacopan and CCX140, selectively blocks a specific chemoattractant receptor, leaving the rest of the immune system intact. The company was founded by Thomas J. Schall in 1997 and is headquartered in Mountain View, CA.